Le Lézard
Classified in: Mining industry, Transportation, Business, Covid-19 virus
Subjects: ERN, ERP, DIV

Leggett & Platt Reports 4Q And Full Year 2020 Results And Announces 1Q Dividend


CARTHAGE, Mo., Feb. 8, 2021 /PRNewswire/ --

Chairman and CEO Karl Glassman commented, "We are pleased to have delivered a strong fourth quarter to end a very challenging 2020. Fourth quarter sales, EBIT, EBIT margin, and earnings per share increased versus the fourth quarter of 2019. For the full year, we generated strong operating cash flow, reduced debt levels, maintained significant liquidity, and increased the dividend for the 49th consecutive year.

"I would like to thank our employees for their dedication, ingenuity, and tenacity in what was a very challenging year as a result of the COVID-19 pandemic. Our teams across our corporate functions and businesses came together to find solutions and navigate the many issues that resulted from the global pandemic. I am extremely proud of all they accomplished. We finished 2020 as a stronger company as a result of their extraordinary efforts. 

"We expect continued recovery into 2021 as a result of strong consumer demand for home-related items and global automotive, and modest improvement in our businesses in industries that are experiencing ongoing impacts from COVID-19.  We also expect continued supply chain constraints, inflation in commodity costs, and recovery of those higher costs through selling price increases."

FOURTH QUARTER RESULTS
Fourth quarter 2020 sales of $1.182 billion, a 3% increase versus fourth quarter 2019.

Fourth quarter EBIT was $150 million, up $15 million or 11% from fourth quarter 2019, and up $10 million or 7% from fourth quarter 2019 adjusted1 EBIT.

Fourth quarter EPS was $.76, a fourth quarter record. EPS increased $.12 versus fourth quarter 2019 and $.08 versus adjusted1 EPS in fourth quarter 2019. Improved EBIT was the primary driver of the increase, augmented by lower interest expense ($.01 per share) and a lower tax rate ($.02 per share).

FULL YEAR RESULTS
2020 sales of $4.28 billion, a 10% decrease versus 2019.

2020 EBIT was $401 million, down $113 million or 22% from 2019, and adjusted1 EBIT was $446 million, an $83 million or 16% decrease.

2020 EPS was $1.82, a decrease of $.65 versus 2019. Full year adjusted1 EPS was $2.13, a decrease of $.44, reflecting lower adjusted1 EBIT.

2020 DEBT, CASH FLOW, AND DIVIDEND

LIQUIDITY AND BALANCE SHEET

DIVIDEND

2021 GUIDANCE

SEGMENT RESULTS ? Fourth Quarter 2020 (versus 4Q 2019)

Bedding Products ?

Specialized Products ?

Furniture, Flooring & Textile Products ?

SEGMENT RESULTS ? Full Year 2020 (versus 2019)

Bedding Products ?

Specialized Products ?

Furniture, Flooring & Textile Products ?

SLIDES AND CONFERENCE CALL
A set of slides containing summary financial information is available from the Investor Relations section of Leggett's website at www.leggett.com. Management will host a conference call at 7:30 a.m. Central (8:30 a.m. Eastern) on Tuesday, February 9. The webcast can be accessed from Leggett's website. The dial-in number is (201) 689-8341; there is no passcode. 

First quarter results will be released after the market closes on Monday, May 3, 2021, with a conference call the next morning.

FOR MORE INFORMATION: Visit Leggett's website at www.leggett.com.

COMPANY DESCRIPTION:  At Leggett & Platt (NYSE: LEG), we create innovative products that enhance people's lives, generate exceptional returns for our shareholders, and provide sought-after jobs in communities around the world. L&P is a 138-year-old diversified manufacturer that designs and produces engineered products found in most homes and automobiles. The Company is comprised of 15 business units, 20,000 employee-partners, and 132 manufacturing facilities located in 17 countries.

Leggett & Platt is the leading U.S.-based manufacturer of: a) bedding components; b) automotive seat support and lumbar systems; c) specialty bedding foams and private label finished mattresses; d) components for home furniture and work furniture; e) flooring underlayment; f) adjustable beds; and g) bedding industry machinery.

FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements," including, but not limited to, strong consumer demand for home-related items and global automotive; modest improvement in COVID-19 impacted businesses; continued supply chain constraints, continued inflation in commodity costs; recovery of commodity costs through selling price increases; raw material-related price increases; volume growth; acquisition and divestiture activity; LIFO impact; the amount of sales, EPS, capital expenditures, depreciation and amortization, net interest expense, fully diluted shares, operating cash flow; our EBIT margin, and effective tax rate and amount of dividends. Such forward-looking statements are expressly qualified by the cautionary statements described in this provision and reflect only the beliefs of Leggett or its management at the time the statement is made. Because all forward-looking statements deal with the future, they are subject to risks, uncertainties and developments which might cause actual events or results to differ materially from those envisioned or reflected in any forward-looking statement. Moreover, we do not have, and do not undertake, any duty to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement was made. Some of these risks and uncertainties include: (i) the adverse impact on our sales, earnings, liquidity, cash flow, costs, and financial condition caused by the COVID-19 pandemic which has, in varying degrees, and could continue to materially negatively impact (a) the demand for our products and our customers' products, growth rates in the industries in which we participate, and opportunities in those industries (b) our manufacturing facilities' ability to remain open or fully operational, obtain necessary raw materials (including nonwoven fabrics) and parts, maintain appropriate labor levels and ship finished products to customers, (c) operating costs related to pay and benefits for our terminated employees, (d) our ability to collect trade and other notes receivables in accordance with their terms; (e) impairment of goodwill and long-lived assets, (f) restructuring-related costs, and (g) our ability to access the commercial paper market or borrow under our revolving credit facility, including compliance with restrictive covenants that may limit our operational flexibility and our ability to timely pay our debt; (ii) the speed at which vaccines for the COVID-19 virus are administered, the percentage of the population vaccinated, and the effectiveness of those vaccines; (iii) the Company's ability to manage working capital; (iv) increases or decreases in our capital needs, which may vary depending on acquisition or divestiture activity, our working capital needs and capital expenditures; (v) market conditions; (vi) price and product competition from foreign and domestic competitors, (vii) cost and availability of raw materials (including chemicals), labor, and energy costs, (viii) cash generation sufficient to pay the dividend, (ix) cash repatriation from offshore accounts; (x) changing tax rates, increased trade costs, cybersecurity breaches, customer losses and insolvencies, disruption to our steel rod mill, foreign currency fluctuation, the imposition or continuation of anti-dumping duties on innersprings, steel wire rod and mattresses, gain on the sale of real estate; data privacy, climate change and ESG obligations, and litigation risks; and (xi) risk factors in the "Forward-Looking Statements" and "Risk Factors" sections in Leggett's most recent Form 10-K and Form 10-Q reports filed with the SEC.

CONTACT:   Investor Relations, (417) 358-8131 or [email protected]
Susan R. McCoy, Senior Vice President, Investor Relations
Cassie J. Branscum, Senior Director, Investor Relations
Tarah L. Sherwood, Director, Investor Relations

1 Please refer to attached tables for Non-GAAP Reconciliations

2 Includes 1% volume reduction attributable to exited business

3 Includes 2% volume reduction attributable to exited business

4 Includes 1% volume reduction attributable to exited business

 

LEGGETT & PLATT











RESULTS OF OPERATIONS 


FOURTH QUARTER


YEAR TO DATE

(In millions, except per share data)


2020


2019


Change


2020


2019


Change

Net trade sales 


$  1,182.0


$  1,144.9


3 %


$  4,280.2


$  4,752.5


(10)%

Cost of goods sold  


923.4


872.5




3,385.7


3,701.9



   Gross profit 


258.6


272.4


(5)%


894.5


1,050.6


(15)%

Selling & administrative expenses 


103.8


117.6


(12)%


424.4


469.7


(10)%

Amortization


16.3


16.0




65.2


63.3



Other expense (income), net


(11.2)


3.7




4.4


4.2



   Earnings before interest and taxes 


149.7


135.1


11 %


400.5

`

513.4


(22)%

Net interest expense


18.8


20.3




79.6


83.3



   Earnings before income taxes 


130.9


114.8




320.9


430.1



Income taxes 


27.7


27.9




73.2


96.2



   Net earnings


103.2


86.9




247.7


333.9



Less net income from non-controlling interest


-


(0.1)




(0.1)


(0.1)



   Net earnings attributable to L&P


$     103.2


$       86.8


19 %


$     247.6


$     333.8


(26)%

Earnings per diluted share 













Net earnings per diluted share


$       0.76


$       0.64


19 %


$       1.82


$       2.47


(26)%

Shares outstanding













   Common stock (at end of period)


132.6


131.8


0.6 %


132.6


131.8


0.6 %

   Basic (average for period)


135.9


135.2




135.7


134.8



   Diluted (average for period)


136.2


135.8


0.3 %


135.9


135.4


0.4 %














CASH FLOW


FOURTH QUARTER


YEAR TO DATE

(In millions)


2020


2019


Change


2020


2019


Change

Net earnings


$     103.2


$       86.9




$     247.7


$     333.9



Depreciation and amortization


48.4


47.2




189.4


191.9



Working capital decrease (increase)


69.9


101.1




92.5


80.5



Impairments


-


2.1




29.4


7.8



Other operating activities


(2.7)


14.1




43.6


53.9



   Net Cash from Operating Activities


$     218.8


$     251.4


(13)%


$     602.6


$     668.0


(10)%

Additions to PP&E


(13.9)


(40.1)




(66.2)


(143.1)



Purchase of companies, net of cash


-


(20.8)




-


(1,265.1)



Proceeds from business and asset sales


8.8


0.2




14.8


5.5



Dividends paid


(53.0)


(52.6)




(211.5)


(204.6)



Repurchase of common stock, net


(0.1)


(2.7)




(9.1)


(7.1)



Additions (payments) to debt, net


(63.1)


(127.5)




(227.8)


947.0



Other


6.4


(2.3)




(1.5)


(21.1)



   Increase (Decr.) in Cash & Equiv.


$     103.9


$        5.6




$     101.3


$      (20.5)
















FINANCIAL POSITION


December 31,







(In millions)


2020


2019


Change







Cash and equivalents 


$     348.9


$     247.6









Receivables 


563.6


591.9









Inventories 


645.5


636.7









Other current assets 


54.1


61.9









   Total current assets 


1,612.1


1,538.1


5 %







Net fixed assets 


784.8


830.8









Operating lease right-of-use assets


161.6


158.8









Goodwill


1,388.8


1,406.3









Intangible assets and deferred costs


806.7


882.4









   TOTAL ASSETS


$  4,754.0


$  4,816.4


(1)%







Trade accounts payable


$     552.2


$     463.4









Current debt maturities 


50.9


51.1









Current operating lease liabilities


42.4


39.3









Other current liabilities 


360.5


374.3









   Total current liabilities 


1,006.0


928.1


8 %







Long-term debt


1,849.3


2,066.5


(11)%







Operating lease liabilities


122.1


121.6









Deferred taxes and other liabilities 


386.3


387.7









Equity


1,390.3


1,312.5


6 %







   Total Capitalization 


3,748.0


3,888.3


(4)%







   TOTAL LIABILITIES & EQUITY


$  4,754.0


$  4,816.4


(1)%




















 

LEGGETT & PLATT












SEGMENT RESULTS 1


FOURTH QUARTER


YEAR TO DATE


(In millions)


2020


2019


Change


2020


2019


Change


Bedding Products














Trade Sales


$     548.3


$     530.2


3 %


$  2,039.3


$  2,254.3


(10)%


EBIT


63.6


57.5


11 %


185.8


235.8


(21)%


EBIT Margin


11.6%


10.8%


80 bps

2

9.1%


10.5%


-140 bps

 

Note impairment


-


-




8.4


-




Restructuring-related charges


-


2.1




3.3


9.0




ECS transaction costs


-


-




-


0.9




Adjusted EBIT


63.6


59.6


7 %


197.5


245.7


(20)%


Adjusted EBIT Margin


11.6%


11.2%


40 bps


9.7%


10.9%


-120 bps


Depreciation and amortization


27.0


26.8




106.7


107.3




Adjusted EBITDA


90.6


86.4


5 %


304.2


353.0


(14)%


Adjusted EBITDA Margin


16.5%


16.3%


20 bps


14.9%


15.7%


-80 bps
















Specialized Products














Trade Sales


$     273.0


$     269.7


1 %


$     891.2


$  1,066.8


(16)%


EBIT


51.2


48.9


5 %


91.9


170.5


(46)%


EBIT Margin


18.8%


18.1%


70 bps


10.3%


16.0%


-570 bps


Restructuring-related charges


-


-




3.8


-




Goodwill  impairment


-


-




25.4


-




Adjusted EBIT


51.2


48.9


5 %


121.1


170.5


(29)%


Adjusted EBIT Margin


18.8%


18.1%


70 bps


13.6%


16.0%


-240 bps


Depreciation and amortization


11.8


10.8




44.3


41.8




Adjusted EBITDA


63.0


59.7


6 %


165.4


212.3


(22)%


Adjusted EBITDA Margin


23.1%


22.1%


100 bps


18.6%


19.9%


-130 bps
















Furniture, Flooring & Textile Products














Trade Sales


$     360.7


$     345.0


5 %


$  1,349.7


$  1,431.4


(6)%


EBIT


34.6


28.2


23 %


126.2


107.4


18 %


EBIT Margin


9.6%


8.2%


140 bps


9.4%


7.5%


190 bps


Restructuring-related charges


-


2.9




1.5


6.1




Adjusted EBIT


34.6


31.1


11 %


127.7


113.5


13 %


Adjusted EBIT Margin


9.6%


9.0%


60 bps


9.5%


7.9%


160 bps


Depreciation and amortization


6.4


6.0




25.5


25.7




Adjusted EBITDA


41.0


37.1


11 %


153.2


139.2


10 %


Adjusted EBITDA Margin


11.4%


10.8%


60 bps


11.4%


9.7%


170 bps
















Total Company














Net Trade Sales


$  1,182.0


$  1,144.9


3 %


$  4,280.2


$  4,752.5


(10)%


EBIT - segments


149.4


134.6


11 %


403.9


513.7


(21)%


Intersegment eliminations and other


0.3


0.5




(3.4)


(0.3)




EBIT


149.7


135.1


11 %


400.5


513.4


(22)%


EBIT Margin


12.7%


11.8%


90 bps


9.4%


10.8%


-140 bps


 Goodwill impairment 3


-


-




25.4


-




 Note impairment 3


-


-




8.4


-




 Stock write-off from prior year divestiture 3


-


-




3.5


-




 Restructuring-related charges3


-


5.0




8.6


15.1




 ECS transaction costs 3


-


-




-


0.9




Adjusted EBIT 3


149.7


140.1


7 %


446.4


529.4


(16)%


Adjusted EBIT Margin 3


12.7%


12.2%


50 bps


10.4%


11.1%


-70 bps


Depreciation and amortization - segments


45.2


43.6




176.5


174.8




Depreciation and amortization - unallocated 4


3.2


3.6




12.9


17.1




Adjusted EBITDA 3


$     198.1


$     187.3


6 %


$     635.8


$     721.3


(12)%


Adjusted EBITDA Margin


16.8%


16.4%


40 bps


14.9%


15.2%


-30 bps
















LAST SIX QUARTERS


2019


2020


Selected Figures 


3Q


4Q


1Q


2Q


3Q


4Q


Net Trade Sales ($ million)


1,239.3


1,144.9


1,045.5


845.1


1,207.6


1,182.0


Sales Growth (vs. prior year)


14 %


9 %


(9)%


(30)%


(3)%


3 %


Volume Growth (same locations vs. prior year)


(1)%


(1)%


(9)%


(29)%


(3)%


3 %
















Adjusted EBIT 3


147.9


140.1


92.6


51.1


153.0


149.7


Cash from Operations ($ million) 


212.9


251.4


10.4


112.1


261.3


218.8
















Adjusted EBITDA (trailing twelve months) 3


689.1


721.3


709.7


621.3


625.0


635.8


(Long-term debt + current maturities - cash and equivalents) / Adj. EBITDA 3,5


2.91


2.59


2.76


3.10


2.74


2.44
















Organic Sales (vs. prior year) 6


3Q


4Q


1Q


2Q


3Q


4Q


Bedding Products


(9)%


(10)%


(15)%


(28)%


(1)%


5 %


Specialized Products


5 %


4 %


(11)%


(47)%


(9)%


1 %


Furniture, Flooring & Textile Products


1 %


(2)%


(7)%


(25)%


(2)%


3 %


     Overall 


(2)%


(4)%


(12)%


(31)%


(3)%


3 %
















1Segment and overall company margins calculated on Trade sales.


2bps = basis points; a unit of measure equal to 1/100th of 1%.


3Refer to next page for non-GAAP reconciliations.


4Consists primarily of depreciation of non-operating assets.


5EBITDA based on trailing twelve months. 














6Trade sales excluding sales attributable to acquisitions and divestitures consummated in the last 12 months.


 

LEGGETT & PLATT













RECONCILIATION OF REPORTED (GAAP) TO ADJUSTED (Non-GAAP) FINANCIAL MEASURES 11




















Full Year


2019


2020

Non-GAAP adjustments 7


2019


2020


3Q


4Q


1Q


2Q


3Q


4Q

Goodwill impairment


-


25.4


-


-


-


25.4


-


-

Note impairment


-


8.4


-


-


8.4


-


-


-

Stock write-off from prior year divestiture


-


3.5


-


-


3.5


-


-


-

Restructuring-related charges


15.1


8.6


3.8


5.0


-


2.9


5.7


-

ECS transaction costs


0.9


-


-


-


-


-


-


-

Non-GAAP adjustments (pretax) 8


16.0


45.9


3.8


5.0


11.9


28.3


5.7


-

Income tax impact


(2.3)


(4.6)


(0.4)


(0.1)


(2.9)


(0.4)


(1.3)


-

Non-GAAP adjustments (after tax)


13.7


41.3


3.4


4.9


9.0


27.9


4.4


-


















Diluted shares outstanding


135.4


135.9


135.4


135.8


135.6


135.7


136.1


136.2


















EPS impact of non-GAAP adjustments


0.10


0.31


0.02


0.04


0.07


0.21


0.03


-




















Full Year


2019


2020

Adjusted EBIT, EBITDA, Margin, and EPS 7


2019


2020


3Q


4Q


1Q


2Q


3Q


4Q

Net trade sales


4,752.5


4,280.2


1,239.3


1,144.9


1,045.5


845.1


1,207.6


1,182.0


















EBIT (earnings before interest and taxes)


513.4


400.5


144.1


135.1


80.7


22.8


147.3


149.7

Non-GAAP adjustments (pretax and excluding interest)


16.0


45.9


3.8


5.0


11.9


28.3


5.7


-

Adjusted EBIT ($ millions)


529.4


446.4


147.9


140.1


92.6


51.1


153.0


149.7


















EBIT margin


10.8%


9.4%


11.6%


11.8%


7.7%


2.7%


12.2%


12.7%

Adjusted EBIT margin


11.1%


10.4%


11.9%


12.2%


8.9%


6.0%


12.7%


12.7%


















EBIT


513.4


400.5


144.1


135.1


80.7


22.8


147.3


149.7

Depreciation and Amortization


191.9


189.4


48.4


47.2


47.5


46.5


47.0


48.4

EBITDA


705.3


589.9


192.5


182.3


128.2


69.3


194.3


198.1

Non-GAAP adjustments (pretax and excluding interest)


16.0


45.9


3.8


5.0


11.9


28.3


5.7


-

Adjusted EBITDA ($ millions)


721.3


635.8


196.3


187.3


140.1


97.6


200.0


198.1


















EBITDA margin


14.8%


13.8%


15.5%


15.9%


12.3%


8.2%


16.1%


16.8%

Adjusted EBITDA margin


15.2%


14.9%


15.8%


16.4%


13.4%


11.5%


16.6%


16.8%


















Diluted EPS


2.47


1.82


0.74


0.64


0.34


(0.05)


0.77


0.76

EPS impact of non-GAAP adjustments


0.10


0.31


0.02


0.04


0.07


0.21


0.03


-

Adjusted EPS ($)


2.57


2.13


0.76


0.68


0.41


0.16


0.80


0.76




















Full Year


2019


2020

Net Debt to Adjusted EBITDA 9


2019


2020


3Q


4Q


1Q


2Q


3Q


4Q

Total Debt


2,117.6


1,900.2


2,248.3


2,117.6


2,466.4


2,134.3


1,960.2


1,900.2

Less: Cash and equivalents


(247.6)


(348.9)


(242.0)


(247.6)


(505.8)


(208.8)


(245.0)


(348.9)

Net Debt


1,870.0


1,551.3


2,006.3


1,870.0


1,960.6


1,925.5


1,715.2


1,551.3


















Adjusted EBITDA, trailing 12 months


721.3


635.8


689.1


721.3


709.7


621.3


625.0


635.8


















Net Debt / Leggett Reported 12-month Adjusted EBITDA


2.59


2.44


2.91


2.59


2.76


3.10


2.74


2.44

Net Debt / Leggett and ECS 12-month Pro Forma Adjusted EBITDA 10


2.59




2.81


2.59


























7  Management and investors use these measures as supplemental information to assess operational performance.

8  The non-GAAP adjustments affected various line items on the income statement. Details by quarter:  3Q 2019: ($0.9) million COGS, $4.7 million other expense. 
    4Q 2019: $5.0 million other expense.  1Q 2020: $8.4 million SG&A, $3.5 million other expense.  2Q 2020: $0.5 COGS, $27.8 million other expense.  3Q 2020: $5.1 million
    other expense, $0.6 million in COGS.

9  Management and investors use this ratio as supplemental information to assess ability to pay off debt.  These ratios are calculated differently than the Company's credit
    facility covenant ratio.

10The Leggett and ECS pro forma adjusted EBITDA for the 12 months ended September 30, and December 31, 2019 is presented in the table below.
     Because the increase in debt from December 31, 2018 to December 31, 2019 was directly attributable to the ECS acquisition, we believe it is more meaningful to
     investors to include ECS's pre-acquisition adjusted EBITDA for the trailing 12 months ended September 30, and December 31, 2019 in the net
     debt / 12-month adjusted EBITDA calculation.


















ECS pre-acquisition adjusted EBITDA from:






10/1/18 ?
1/16/19


1/1/19 ? 
1/16/19









Net earnings






-


(1)









Interest expense






12


1









Taxes






1


-









EBIT






13


-









Depreciation and Amortization






5


1









Change in control bonus






7


-









EBITDA






25


1


























Leggett Adjusted EBITDA, trailing 12 months (including ECS from January 16, 2019)




689


721









ECS pre-acquisition adjusted EBITDA






25


1









Leggett and ECS Pro Forma Adjusted EBITDA, trailing 12 months






714


722









Net Debt / Leggett and ECS 12-month Pro Forma Adjusted EBITDA






2.81


2.59


























11Calculations impacted by rounding.

















Leggett & Platt logo

 

SOURCE Leggett & Platt


These press releases may also interest you

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 21:00
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

at 19:30
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:51
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...

at 17:20
Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive...



News published on and distributed by: